Locations:
Search IconSearch
October 17, 2022/Neurosciences/Podcast

Pro Athletes Brain Health Study: The First 10 Years (Podcast)

Longitudinal study is refining understanding of repetitive head impacts in active and retired athletes

The Professional Athletes Brain Health Study, launched by Cleveland Clinic in 2011, examines the cumulative effects of repetitive concussions and subconcussive impacts to the brain in active and retired athletes exposed to repetitive head injuries, including professional fighters and bull riders.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“Chronic traumatic encephalopathy has been most associated with professional football players, but you can see it in any of these contact sports,” says Charles Bernick, MD, MPH, a neurologist in Cleveland Clinic’s Lou Ruvo Center for Brain Health in Las Vegas and one of the study’s principal investigators. “The problem is that we just know very little about it.”

In the latest episode of Cleveland Clinic’s Neuro Pathways podcast, Dr. Bernick discusses findings from the first decade of the longitudinal study and what’s on the horizon. He delves into:

  • Origins of the study, which began as the Professional Fighters Brain Health Study
  • Tests that participants undergo, including MRIs, behavioral health questionnaires, cognitive testing and speech samples
  • Functional and structural changes in the brain caused by repetitive head injuries
  • Potential expansion of the study to include an autopsy component and exploration of socioeconomic and psychosocial influences
  • The role of biomarkers and genetic factors
  • Ideas to prevent head injuries and subsequent long-term effects

Click the podcast player above to listen to the 24-minute episode now, or read on for a short edited excerpt. Check out more Neuro Pathways episodes at clevelandclinic.org/neuropodcast or wherever you get your podcasts.

This activity has been approved for AMA PRA Category 1 Credit™. After listening to the podcast, you can claim your credit here.

Excerpt from the podcast

Dr. Bernick: In our active fighters we see most of the volumetric changes in the thalamus and corpus callosum — these deep structures that either carry a lot of fibers or are connected to a lot of fibers. Yet in the retired fighters the changes we see over time are in the hippocampus and the amygdala.

Advertisement

As a result, we think there may be, in some sense, two things that we are seeing. In active fighters we’re seeing just the result of axonal injury, whereas in retired fighters, those who show progressive decline in the hippocampus and amygdala may have the development of a neurodegenerative process. And we are trying to actually develop some type of classifier using a variety of MRI measures to be able to predict who may actually be on a progressive disease course.

Advertisement

Related Articles

William Clifton, MD, against a decorative background
November 4, 2024/Neurosciences/Podcast
Adult Idiopathic Scoliosis: Essentials of Diagnosis and Treatment (Podcast)

Early intervention yields the best outcomes, but surgery can benefit older patients as well

Creative illustration of a brain
October 16, 2024/Neurosciences/Podcast
Diagnosing Atypical Parkinsonian Disorders (Podcast)

Patient history plays a key role in identifying the condition

dr. daniel ontaneda against a decorative background
October 2, 2024/Neurosciences/Podcast
Takeaways From the New Diagnostic Criteria for Multiple Sclerosis (Podcast)

A co-author explains some of the key McDonald criteria revisions

Dr. Imad Najm against a decorative background
September 16, 2024/Neurosciences/Podcast
Temporal Lobe Epilepsy and the Potential of Gene Therapy (Podcast)

Investigational gene approaches offer hope for a therapeutically challenging condition

alison stout, DO, against a decorative backdrop
August 9, 2024/Neurosciences/Podcast
Evaluation and Interventional Treatment of Axial Lumbar Back Pain (Podcast)

This common condition remains tough to work up and diagnose, and treatment options are limited

Dr. Amy Kunchok against decorative background
July 16, 2024/Neurosciences/Podcast
What to Know About Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOGAD) (Podcast)

It’s time to get familiar with this emerging demyelinating disorder

receptor activity for myasthenia gravis medications
July 3, 2024/Neurosciences/Podcast
Myasthenia Gravis: Unmet Needs and Efforts to Address Them (Podcast)

An overview of associated antibodies, therapies for antibody-positive disease and the outlook for atypical forms of MG

adult female figure suffering headache
June 17, 2024/Neurosciences/Podcast
Migraine Relief: Providing Preventive and Abortive Therapies (Podcast)

A close look at the growing array of options for episodic and chronic migraine

Ad